Lanreotide Acetate Sustained-release Injection (a pre-filled syringe)

Lanreotide acetate for injection is suitable for patients with acromegaly who have undergone surgery or abnormal growth hormone secretion after radiotherapy. It can also be used after experimental injection for the treatment of clinical symptoms of carcinoid.

The main ingredient of the above-mentioned drug is lanreotide acetate, and its drug properties are white freeze-dried blocks. If the patient is acromegaly, the volume of the pituitary tumor still needs to be monitored when using lanreotide.